Thorne HealthTech, Inc. (THRN) Misses Q3 EPS by 1c; Offers FY22 Guidance
Get Alerts THRN Hot Sheet
Join SI Premium – FREE
Thorne HealthTech, Inc. (NASDAQ: THRN) reported Q3 EPS of $0.12, $0.01 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $58.4 million versus the consensus estimate of $63.25 million.
GUIDANCE:
Thorne HealthTech, Inc. sees FY2022 EPS of $0.34-$0.37, versus the consensus of $0.36. Thorne HealthTech, Inc. sees FY2022 revenue of $232-235 million, versus the consensus of $238 million.
For earnings history and earnings-related data on Thorne HealthTech, Inc. (THRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share